Members of the FBI Healthcare Fraud Division and the U.S. Attorney’s Office will present on issues related to healthcare fraud. The seminars will be of particular interest to physicians, clinical faculty, residents and fellows.
Presentations are scheduled for Thursday, June 16, from 8 to 10 a.m. in the University Hospital auditorium (https://southalabama.zoom.us/j/97788610445) and again from 1 to 3 p.m. in the Atlantis Room in CWEB 2 (https://southalabama.zoom.us/j/96703119325).
“Healthcare Fraud Trends and Opioid Investigation Case Study”
Presenter: Laura Walker, FBI supervisory special agent
“Medical Professionals: Have You Been Ensnared in a Healthcare Fraud?”
Presenter: Paul Baumrind, FBI supervisory special agent
“Current Health Care Fraud Issues”
Areas of focus: Qui tam (in the medical context), COVID fraud, drug diversion, civil and criminal penalties, recent case examples/words of warning
Presenters: Nina Herring, assistant U.S. attorney, civil healthcare fraud coordinator; and Kasee Heisterhagen, assistant U.S. attorney, deputy criminal chief
Presenter Biographies:
Laura Walker has worked as an FBI agent for 16 years and is currently assigned to the Healthcare Fraud Unit at headquarters managing the healthcare fraud program for the south-central region of the United States. Prior to her current assignment, Walker was a case agent at the FBI’s Washington field office for 12 years. During that time, she managed various types of healthcare fraud and drug diversion cases.
Paul Baumrind is assigned to the Healthcare Fraud Unit in Washington, D.C. He has served as a law enforcement officer since 1995, in three different agencies, including the Baltimore County Police Department, United States Federal Air Marshal Service and the Federal Bureau of Investigation. As a special agent in the FBI, Baumrind has worked on the healthcare fraud, organized crime, and public corruption/civil rights squads in Boston. He served as the FBI lead case agent in the case against Pfizer Pharmaceuticals, which resulted in a $2.3 billion settlement and the successful prosecution of the executives of Insys Therapeutics.
Nina Herring is a graduate of the University of Georgia and Cumberland School of Law. She recently started as the civil healthcare fraud coordinator for the U.S. Attorney’s Office for the Southern District of Alabama and was previously an associate at the law firm of Cory Watson Attorneys.
Kasee Heisterhagen is a graduate of Washington and Lee University and the University of Alabama School of Law. She serves as the deputy criminal chief for the U.S. Attorney’s Office for the Southern District of Alabama and was previously a partner at the law firm of Burr & Forman LLP.
For more information, contact Emily Wilson, Ph.D., at emilyw@southalabama.edu.
